• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy.

作者信息

Martini Alberto, Raggi Daniele, Marandino Laura, Montorsi Francesco, Ross Jeffrey S, Gibb Ewan A, Necchi Andrea

机构信息

Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Eur Urol Oncol. 2022 Jun;5(3):370-372. doi: 10.1016/j.euo.2022.02.004. Epub 2022 Mar 10.

DOI:10.1016/j.euo.2022.02.004
PMID:35283158
Abstract
摘要

相似文献

1
The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy.体重指数在接受新辅助免疫治疗的肌层浸润性膀胱癌患者中的矛盾作用。
Eur Urol Oncol. 2022 Jun;5(3):370-372. doi: 10.1016/j.euo.2022.02.004. Epub 2022 Mar 10.
2
Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer.新辅助免疫治疗肌层浸润性膀胱癌。
Medicina (Kaunas). 2021 Jul 29;57(8):769. doi: 10.3390/medicina57080769.
3
The promise and challenges of neoadjuvant immunotherapy in the management of non-metastatic muscle-invasive bladder cancer.
BJU Int. 2020 Jun;125(6):753-755. doi: 10.1111/bju.15025. Epub 2020 Feb 27.
4
Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm?新辅助化疗或免疫治疗用于临床 T2N0 肌肉浸润性膀胱癌：是否需要改变治疗模式？
Eur Urol Oncol. 2021 Dec;4(6):1006-1010. doi: 10.1016/j.euo.2020.07.006. Epub 2020 Aug 23.
5
Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder.新辅助免疫治疗在膀胱癌中的作用及结果。
Eur Urol Oncol. 2020 Dec;3(6):728-738. doi: 10.1016/j.euo.2020.06.009. Epub 2020 Nov 8.
6
Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future.新辅助免疫治疗在膀胱癌中的最新进展：近期内的展望。
Cancer Treat Rev. 2021 Feb;93:102142. doi: 10.1016/j.ctrv.2020.102142. Epub 2021 Jan 5.
7
Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.肌层浸润性膀胱癌和上尿路尿路上皮癌的辅助治疗
Urol Clin North Am. 2018 May;45(2):257-266. doi: 10.1016/j.ucl.2017.12.010. Epub 2018 Feb 21.
8
"Future role of [18F]-FDG PET/CT in patients with bladder cancer in the new era of neoadjuvant immunotherapy?".
Urol Oncol. 2021 Feb;39(2):139-141. doi: 10.1016/j.urolonc.2020.12.003. Epub 2021 Jan 19.
9
Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.浅表性和肌层浸润性膀胱癌：结局评估的管理原则
J Clin Oncol. 2006 Dec 10;24(35):5519-27. doi: 10.1200/JCO.2006.08.5431.
10
A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer.从诊断到新辅助化疗再到根治性膀胱切除术的时间对肌层浸润性膀胱癌患者生存影响的回顾性分析
J Urol. 2016 Apr;195(4 Pt 1):880-5. doi: 10.1016/j.juro.2015.11.024. Epub 2015 Nov 18.

引用本文的文献

1
Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder carcinoma: A narrative review.免疫检查点抑制剂疗法作为肌肉浸润性膀胱癌的新辅助治疗：一项叙述性综述。
Curr Urol. 2025 Jan;19(1):39-42. doi: 10.1097/CU9.0000000000000263. Epub 2024 Nov 14.
2
The Prognostic Role of Body Mass Index on Oncological Outcomes of Upper Tract Urothelial Carcinoma.体重指数对上尿路尿路上皮癌肿瘤学结局的预后作用
Cancers (Basel). 2023 Nov 10;15(22):5364. doi: 10.3390/cancers15225364.